Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSAs commercial pharma leaders implement 2025 strategy, it's already time to start envisioning the next long-term horizon of strategic growth and investment. It's an opportunity to pause, consider which efforts at modernizing the commercial model have worked and what has remained the same, and chart the course for future evolution.
Pharma companies can redefine what their future looks like for the next decade, not just the next launch; it's a time to do big-picture thinking about throughput of R&D spending, gross-to-net accounting, and commercial models in order to future-proof the organization.
In this white paper, IQVIA experts discuss why the innovative commercial models of the future should be built upon a foundation of comprehensive, connected data, with flexible and dynamic allocation of sales and marketing resources, that can drive personalized content and channel orchestration for physicians at the individual and local level.
This introductory piece is the first in a series of white papers on the “Future of Pharma Commercial Models”. In subsequent works, IQVIA experts will go deeper into multiple innovative commercial model designs and share our POV.
IQVIA experts explore the new ideas and trends that will drive successful HCP engagement and customer experience strategy in the year ahead.
Why are most large biopharma and MedTech companies stuck on strategy, rather than exceling at execution when it comes to commercial model innovation?
Use Next Best Action insights to optimize tactics and spend across personal and non-personal channels
Connected, Convenient Customer Data is at the Core of Agile Brand Promotion
MATTHEW SMITH, Senior Principal, New Commercial Models & Digital Health
How small and emerging biopharma organizations leverage Agile Brand Promotion to deliver omnichannel engagement
The customer engagement model of the future is personalized, insight-driven, and dynamic.
Grow your brand, now and through patent expiry